MedinCell to publish its activity report and financial information of the first half of 2019-2020 on December 3, 2019 November 19, 2019 November 19, 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association September 10, 2019 September 10, 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP September 4, 2019 September 4, 2019
MedinCell partners to address the untapped financial potential in Animal Health August 28, 2019 August 28, 2019
Long-acting injectable antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities August 26, 2019 August 26, 2019
Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development July 9, 2019 July 9, 2019
Shareholders audioconference and publication of the results for the 2018-2019 financial year, on June 4, 2019 May 22, 2019 May 22, 2019
